CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-21 | Dougan Brady W Director | Sale | −602,443 | $3.39 | $2.0M | 8,191,140 |
| 2023-08-21 | Ayabudge LLC 10% owner | Sale | −602,443 | $3.39 | $2.0M | 8,191,140 |
| 2023-08-18 | Niklason Laura E President, CEO and Director | Sale | −626,979 | $3.57 | $2.2M | 8,793,583 |
| 2023-08-18 | Dougan Brady W Director | Sale | −626,979 | $3.57 | $2.2M | 8,793,583 |
| 2023-08-18 | Ayabudge LLC 10% owner | Sale | −626,979 | $3.57 | $2.2M | 8,793,583 |
| 2023-08-17 | Niklason Laura E President, CEO and Director | Sale | −570,174 | $3.68 | $2.1M | 9,420,562 |
| 2023-08-17 | Dougan Brady W Director | Sale | −570,174 | $3.68 | $2.1M | 9,420,562 |
| 2023-08-17 | Ayabudge LLC 10% owner | Sale | −570,174 | $3.68 | $2.1M | 9,420,562 |
| 2023-06-15 | Brown Emery N. Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Wallace Max N. Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Green Charles Bruce Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Sebelius Kathleen Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Constantino Michael T. Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Pope Todd Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Binder Gordon M Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Shukla Rajiv Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Windham-Bannister Susan Richards Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Seimetz Diane Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 | ||
| 2023-06-15 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +8,500 | 8,500 |
Page 9 of 17 · 330 trades